StockVS

Forian Inc. (FORA) Análisis de acciones

Salud

Forian Inc.

$2.17

+$0.00 (+0.00%)

Última actualización: 15 de mayo de 2026

Historial de Precios

Análisis

Descripción de la empresa

Forian Inc. operates within the healthcare sector, specifically serving the Health Information Services industry by providing a comprehensive suite of data management capabilities and information analytics solutions. These offerings are designed to optimize and measure operational, clinical, and financial performance for customers across the life science, healthcare, and financial services industries, while also developing commercial and real-world evidence. The company currently employs a workforce of 50 individuals to support its technology and service delivery models. With a market capitalization of $66.86M and trailing twelve-month revenue of $30.26M, Forian Inc. maintains a relatively small market footprint consistent with its lean employee base. These valuation and revenue figures indicate that the company is in a growth phase where market capitalization is driven more by revenue expansion potential than by current profitability, positioning it as a specialized player rather than a large-cap utility in the healthcare data space.

Salud financiera

Forian Inc. reported annual revenue of $30.26M over the trailing twelve months, yet recorded a net income loss of $-2,874,042, while EBITDA stood at $-3,550,385. The substantial gap between the positive revenue figure and the negative net income reveals a cost structure where operating expenses significantly exceed gross profits, likely due to high investment in research, development, or sales infrastructure typical of early-stage technology firms. Despite the accounting losses, the company generated positive free cash flow of $3.90M, which indicates a strong ability to generate liquidity from operations and provides significant financial flexibility for strategic reinvestment without immediate reliance on external financing. The company's profitability margins tell a nuanced story: a gross margin of 53.2% suggests efficient production or service delivery costs, whereas an operating margin of -24.4% and a profit margin of -9.5% highlight that overhead costs are currently consuming the majority of gross profits. On the balance sheet, the firm holds $31.55M in cash against a debt obligation of $12,137, resulting in a conservative debt-to-equity ratio of 0.04 that minimizes financial risk. This liquidity position is further supported by a current ratio of 2.96, which indicates robust short-term liquidity sufficient to cover current liabilities more than twice over. Finally, the return on equity is -9.6% and the return on assets is -5.1%, metrics that reveal management is currently deploying capital to generate negative returns, a common characteristic of companies prioritizing growth and market share acquisition over immediate profitability.

Evaluación de valoración

The valuation metrics for Forian Inc. show a trailing P/E ratio of N/A due to its lack of net income, while the forward P/E is projected at 23.78, implying that the market expects earnings to turn positive and grow significantly in the coming year. The price-to-book ratio stands at 2.23, indicating that the market values the company at a premium of over double its net asset book value, reflecting confidence in its intangible assets and future growth prospects rather than current tangible wealth. Alternative valuation metrics such as the price-to-sales ratio of 2.21 and an EV/EBITDA of -9.93 suggest that investors are pricing the stock based on revenue multiples rather than earnings, a standard approach for profitable companies with temporary losses. The stock has traded between a 52-week low of $1.64 and a 52-week high of $2.71; assuming the current trading price aligns with the forward P/E implication, the stock sits within this established volatility range, though the exact percentage distance from the high or low requires the current spot price which is not explicitly provided in the raw data points, yet the forward multiple suggests a bullish outlook relative to the low. The beta value of 0.99 indicates that the stock's price volatility moves in tandem with the broader market, suggesting it does not offer significant downside protection nor excessive upside leverage compared to the S&P 500.

Growth & Income

Forian Inc. demonstrated a robust revenue growth rate of 37.0% year-over-year, whereas earnings growth is N/A due to the company reporting a net loss, indicating that top-line expansion is outpacing the recovery of profitability. Since the company is not a dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, it follows a capital allocation strategy where earnings are retained and reinvested directly into business growth rather than distributed to shareholders. The absence of a dividend payout is sustainable given the negative net income, as the company prioritizes funding operations and expansion over shareholder distributions. Overall, the growth and income profile is characterized by high revenue acceleration funded by internal cash generation, with no current income distribution to investors, positioning the asset purely for capital appreciation potential.

Comparación con pares

Forian Inc. (FORA) opera en la industria de Servicios de Información de Salud. Así se compara con sus pares más cercanos por capitalización de mercado:

Empresa Ticker Cap. de Mercado Ratio P/E
Forian Inc. FORA $67.79M N/A
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

El ratio P/E promedio de la industria Servicios de Información de Salud es 57.5x. Forian Inc. cotiza a un P/E de N/A.

Este análisis es generado por IA solo con fines informativos y no constituye asesoramiento financiero. Los datos pueden estar retrasados o ser inexactos. Siempre realice su propia investigación y consulte a un asesor financiero calificado antes de tomar decisiones de inversión.

Acerca de Forian Inc.

Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc. operates as a subsidiary of 2025 Acquisition Company, LLC.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →

Estadísticas Clave

Capitalización
$67.79M
Ratio P/E
N/A
Máximo 52 Sem.
$2.71
Mínimo 52 Sem.
$1.64
Volumen Promedio
29.93K

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Bolsa
NASDAQ
País
United States
Empleados
50